{"result": "(\"entity\"<|>GLUCOSE<|>EVENT<|>Glucose is a simple sugar that is a primary energy source for the body, and its administration is critical in managing patients with pancreatitis.)\n##\n(\"entity\"<|>LIPIDS<|>EVENT<|>Lipids are fats that are essential for energy and cellular function, but their administration in patients with pancreatitis is controversial due to potential complications.)\n##\n(\"entity\"<|>TRIGLYCERIDES<|>EVENT<|>Triglycerides are a type of fat found in the blood, and elevated levels can be associated with pancreatitis, necessitating monitoring in affected patients.)\n##\n(\"entity\"<|>HYPERGLYCEMIA<|>EVENT<|>Hyperglycemia is a condition characterized by elevated blood glucose levels, which can occur in patients with severe pancreatitis due to metabolic disturbances.)\n##\n(\"entity\"<|>HEPATIC STEATOSIS<|>EVENT<|>Hepatic steatosis, or fatty liver, can develop in patients with pancreatitis, particularly if glucose is administered excessively.)\n##\n(\"entity\"<|>HYPOCALCEMIA<|>EVENT<|>Hypocalcemia is a condition of low calcium levels in the blood, which can occur in patients with pancreatitis and is influenced by various metabolic factors.)\n##\n(\"entity\"<|>ALCOHOLISM<|>EVENT<|>Alcoholism is a significant risk factor for developing pancreatitis and can contribute to nutritional deficiencies in affected patients.)\n##\n(\"relationship\"<|>GLUCOSE<|>PA<|>The administration of glucose is critical in managing patients with pancreatitis, but excessive amounts can lead to complications like hyperglycemia and hepatic steatosis<|>8)\n##\n(\"relationship\"<|>LIPIDS<|>PA<|>The use of lipids in nutritional support for pancreatitis patients is controversial due to their potential association with hyperlipemia and pancreatitis<|>5)\n##\n(\"relationship\"<|>TRIGLYCERIDES<|>PA<|>Monitoring triglyceride levels is essential in patients with pancreatitis to prevent complications<|>7)\n##\n(\"relationship\"<|>HYPERGLYCEMIA<|>PA<|>Hyperglycemia is a common metabolic disturbance in patients with severe pancreatitis<|>6)\n##\n(\"relationship\"<|>HEPATIC STEATOSIS<|>PA<|>Hepatic steatosis can develop in patients with pancreatitis, particularly due to excessive glucose administration<|>6)\n##\n(\"relationship\"<|>HYPOCALCEMIA<|>PA<|>Hypocalcemia is frequently observed in patients with pancreatitis and is related to the severity of the condition<|>7)\n##\n(\"relationship\"<|>ALCOHOLISM<|>PA<|>Alcoholism is a significant contributing factor to the development of pancreatitis and its associated metabolic disorders<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: junto a cierta resistencia de esta última y la disminución del aclaramiento de la glucosa, dan lugar a hiperglucemia en el 90% de los casos de PA severa. Para evitar el desarrollo de una esteatosis hepática, no se debe administrar más de 5 mg/kg/min de glucosa intravenosa1.\n\n- El metabolismo lipídico se ve también alterado. El uso de emulsiones lipídicas es controvertido, debido a su asociación etiológica entre hiperlipemia y pancreatitis, por ello se deben monitorizar los niveles de triglicéridos (TG) y suspender la administración de estas si se superan los 400 mg/dl33. Si los niveles séricos de TG son normales, se debería administrar una dosis test de 100 ml de solución lipídica al 20%: si es bien tolerada, se pueden administrar hasta el 30% de las calorías no proteicas en forma de grasas, evaluando semanalmente los\n---\nTema 29. Soporte nutricional en enfermedades pancreáticas 471\n\nniveles de TG. Existen varias razones fisiológicas para recomendar su uso, la administración solo de glucosa aumenta el riesgo de hiperglucemia y esteatosis hepática; además, la administración de lípidos intravenosos a la solución glucosada mejora el balance nitrogenado en pacientes con NPT, incluyendo los pacientes con PA4.\n\n- La hipocalcemia se presenta en el 40-60% de los pacientes con PA y depende de la severidad de la enfermedad, siendo los niveles más bajos los observados en los primeros 3 días. Se debe a la saponificación del calcio con los ácidos grasos libres, la hipoalbuminemia y la hipomagnesemia, así como al incremento de la liberación de calcitonina y la reducción de la secreción de la parathormona34, 35.\n\n- Inicialmente, la deficiencia de micronutrientes como la tiamina, al ácido fólico y el zinc contribuyen a los trastornos metabólicos de los pacientes con PA, especialmente en los alcohólicos34, 35.\n\n## 2.5. Dietética\n\nEn la mayoría de los pacientes con PA (85-90%) la enfermedad es de evolución limitada y cede espontáneamente en general de 3 a 7 días después de instaurado el tratamiento, por lo que en estos casos se suele dejar en dieta absoluta para evitar el estímulo secretor de la glándula y se inicia dieta oral tras los primeros 5 a 7 días, si no hay complicaciones intercurrentes. Siguiendo las recomendaciones de la Sociedad Europea de Nutrición Clínica y Metabolismo (ESPEN) publicadas en el 200629 en los casos de PA leves y moderadas solo se deben aplicar las medidas generales anteriormente comentadas, planteando un soporte nutricional únicamente en aquellos casos en los que la reintroducción de la dieta oral se tenga que retrasar más allá de 7 días, pues se ha demostrado que el soporte nutricional en estos casos no aporta ningún beneficio33.\n\nEn las PA leves se aconseja introducir dieta oral cuando el dolor haya cedido durante, al menos, 48 horas, se normalicen los niveles de amilasa y/o lipasa plasmáticos y no existan complicaciones, comprobando previamente que existe motilidad intestinal. En principio, se deberán dar pequeñas tomas a lo largo del día, con aporte fundamentalmente de hidratos de carbono y pocas proteínas. Las grasas se introducirán de forma tardía (a partir del tercer o cuarto día). En una quinta parte de los casos el dolor reaparece de nuevo con la ingesta oral, pero no suele ser necesario en estos casos suspenderla4.\n\n### 2.5.1. Soporte nutricional artificial\n\nPara conocer si un paciente va a necesitar un soporte nutricional artificial se debe valorar al ingreso su estado nutricional, así como el riesgo de desnutrición que puede llegar a presentar2. Los pacientes con desnutrición previa deberían recibir soporte desde el inicio, aunque hay siempre que valorar cada paciente de forma individual.\n\nEn la PA severa el soporte nutricional es imprescindible, puesto que la situación del paciente en estos casos va a prolongar su período de ayuno durante un tiempo indefinido y el estado hiperdinámico al que está sometido puede llevarle rápidamente a un deterioro franco de su estado nutricional. Diversos estudios han comparado la NE con la NPT analizando sus ventajas e inconvenientes.\n\nLa NPT ha sido el soporte nutricional fundamental para tratar al paciente con PA severa, sin embargo, diversos estudios han demostrado las desventajas que presenta respecto a la NE, por lo que se puede decir que ha quedado relegada a un segundo plano frente a esta19, 20, 24, 26, 27, 36, 37. Marik et al22 realizaron un metanálisis con seis estudios donde comparaban ambos soportes nutric\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>PA<|>EVENT<|>PA refers to pancreatitis, a condition that can lead to various metabolic disturbances and requires careful nutritional support.)\n##\n(\"entity\"<|>ESPEN<|>ORGANIZATION<|>The European Society for Clinical Nutrition and Metabolism (ESPEN) provides guidelines for nutritional support in patients with pancreatitis.)\n##\n(\"entity\"<|>NPT<|>EVENT<|>Nutritional Parenteral Therapy (NPT) is a method of providing nutrition to patients who cannot eat or absorb food normally, particularly important in severe cases of pancreatitis.)\n##\n(\"entity\"<|>NE<|>EVENT<|>Nutritional Enteral therapy (NE) is a method of providing nutrition directly into the gastrointestinal tract, which has advantages over NPT in treating patients with pancreatitis.)\n##\n(\"entity\"<|>MICRONUTRIENTS<|>EVENT<|>Micronutrients such as thiamine, folic acid, and zinc are essential for metabolic processes and their deficiency can contribute to metabolic disorders in patients with pancreatitis.)\n##\n(\"relationship\"<|>ESPEN<|>PA<|>ESPEN provides guidelines for managing nutritional support in patients with pancreatitis<|>8)\n##\n(\"relationship\"<|>NPT<|>PA<|>NPT is a critical nutritional support method for patients suffering from severe pancreatitis<|>9)\n##\n(\"relationship\"<|>NE<|>PA<|>NE is considered a more advantageous nutritional support method compared to NPT for patients with pancreatitis<|>7)\n##\n(\"relationship\"<|>MICRONUTRIENTS<|>PA<|>Deficiencies in micronutrients can exacerbate metabolic disorders in patients with pancreatitis<|>6)\n<|COMPLETE|>"}]}